Difference between revisions of "Resource:08657792-f22e-486e-a034-c78fb9a2f39f"
From The Embassy of Good Science
Marc.VanHoof (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Resource | {{Resource | ||
|Resource Type=Cases | |Resource Type=Cases | ||
| − | |Title=Faulty | + | |Title=Faulty Drug Trials Tarnish Japan's Clinical Research |
| − | |Is About=The | + | |Is About=The case describes a clinical trial of an existing drug in Japan. Several universities performed the trial in collaboration with a large pharmaceutical company. The drug did not work as expected, and the researchers tried to bury the results. Eventually the case came to light, resulting in an elaborate apology from the researchers. |
| − | |Important Because= | + | |Important Because=Pharmaceutical companies and drug manufactures "fund such studies hoping to show that their drugs cause fewer side effects or are more effective than competing products."<ref>Normile, Dennis. "Faulty drug trials tarnish Japan's clinical research." (2014): 17-17.</ref> Rules and regulations related to studying existing drugs need to be adapted to showcase transparency and to ensure results - positive or negative- are published. |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|Important For=Researchers | |Important For=Researchers | ||
}} | }} | ||
| Line 14: | Line 9: | ||
|Has Link=https://science.sciencemag.org/content/345/6192/17.full | |Has Link=https://science.sciencemag.org/content/345/6192/17.full | ||
}} | }} | ||
| − | {{Related To}} | + | {{Related To |
| + | |Related To Resource=Resource:226c89f1-a061-4bb0-8ec4-79583de2ddf0;Resource:E273cee3-0907-4841-9126-9cee08518338;Resource:270a135c-cf51-4a57-81b7-cdd162ea8fdf | ||
| + | |Related To Theme=Theme:047c3bec-1747-499b-b6d5-684cbfb81edd;Theme:0bb5e4f7-9336-4ca8-92e3-c506413d1450 | ||
| + | }} | ||
{{Tags | {{Tags | ||
| + | |Has Timepoint=2014 | ||
|Has Location=Japan | |Has Location=Japan | ||
|Has Virtue And Value=Respect | |Has Virtue And Value=Respect | ||
| − | |Has Good Practice And Misconduct=Privacy | + | |Has Good Practice And Misconduct=Privacy; Factual case |
|Related To Research Area=Clinical medicine | |Related To Research Area=Clinical medicine | ||
}} | }} | ||
Latest revision as of 09:41, 17 September 2020
ResourcesCases
Faulty Drug Trials Tarnish Japan's Clinical Research
What is this about?
The case describes a clinical trial of an existing drug in Japan. Several universities performed the trial in collaboration with a large pharmaceutical company. The drug did not work as expected, and the researchers tried to bury the results. Eventually the case came to light, resulting in an elaborate apology from the researchers.
Why is this important?
Pharmaceutical companies and drug manufactures "fund such studies hoping to show that their drugs cause fewer side effects or are more effective than competing products."[1] Rules and regulations related to studying existing drugs need to be adapted to showcase transparency and to ensure results - positive or negative- are published.
For whom is this important?
Other information
When
Where
Virtues & Values
Good Practices & Misconduct
Research Area
- ↑ Normile, Dennis. "Faulty drug trials tarnish Japan's clinical research." (2014): 17-17.
